160 related articles for article (PubMed ID: 9607853)
1. Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt's lymphoma cell line.
Srinivas SK; Sample JT; Sixbey JW
J Infect Dis; 1998 Jun; 177(6):1705-9. PubMed ID: 9607853
[TBL] [Abstract][Full Text] [Related]
2. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
[TBL] [Abstract][Full Text] [Related]
3. IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells.
Gao Y; Wang L; Lei Z; Li J; Forrest JC; Liang X
J Gen Virol; 2019 May; 100(5):851-862. PubMed ID: 30907723
[TBL] [Abstract][Full Text] [Related]
4. Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site.
Wolf J; Jox A; Skarbek H; Pukrop T; Bartnitzke S; Pawlita M; Diehl V; Bullerdiek J
Virology; 1995 Sep; 212(1):179-85. PubMed ID: 7676627
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
De Leo A; Arena G; Stecca C; Raciti M; Mattia E
Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
[TBL] [Abstract][Full Text] [Related]
6. Replacement of the Epstein-Barr virus plasmid with the EBER plasmid in Burkitt's lymphoma cells.
Maruo S; Nanbo A; Takada K
J Virol; 2001 Oct; 75(20):9977-82. PubMed ID: 11559830
[TBL] [Abstract][Full Text] [Related]
7. Non-Random Pattern of Integration for Epstein-Barr Virus with Preference for Gene-Poor Genomic Chromosomal Regions into the Genome of Burkitt Lymphoma Cell Lines.
Janjetovic S; Hinke J; Balachandran S; Akyüz N; Behrmann P; Bokemeyer C; Dierlamm J; Murga Penas EM
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062290
[TBL] [Abstract][Full Text] [Related]
8. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
Doyle MG; Crawford DH
Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus integrates frequently into chromosome 4q, 2q, 1q and 7q of Burkitt's lymphoma cell line (Raji).
Gao J; Luo X; Tang K; Li X; Li G
J Virol Methods; 2006 Sep; 136(1-2):193-9. PubMed ID: 16806502
[TBL] [Abstract][Full Text] [Related]
10. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
11. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma.
Razzouk BI; Srinivas S; Sample CE; Singh V; Sixbey JW
J Infect Dis; 1996 Mar; 173(3):529-35. PubMed ID: 8627013
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus (EBV) hypersensitivity of peripheral B lymphocytes in patients with EBV genome-positive Burkitt's lymphoma.
Okano M; Mizuno F; Osato T
J Infect; 1995 Jul; 31(1):15-9. PubMed ID: 8522826
[TBL] [Abstract][Full Text] [Related]
14. State of Epstein-Barr virus DNA in an American Burkitt's lymphoma line.
Koliais S; Bjursell G; Adams A; Lindahl T; Klein G
J Natl Cancer Inst; 1978 May; 60(5):991-4. PubMed ID: 205666
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of Epstein-Barr virus (EBV) BMRF1 protein EA-D during latent EBV activation of Burkitt's lymphoma cell line Raji.
Ohashi M; Horie K; Hoshikawa Y; Nagata K; Osaki M; Ito H; Sairenji T
Microbes Infect; 2007 Feb; 9(2):150-9. PubMed ID: 17223371
[TBL] [Abstract][Full Text] [Related]
16. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV.
Shimizu N; Tanabe-Tochikura A; Kuroiwa Y; Takada K
J Virol; 1994 Sep; 68(9):6069-73. PubMed ID: 8057484
[TBL] [Abstract][Full Text] [Related]
17. Integration of Epstein Barr virus near the breakpoint of a translocation 11;19 in a Burkitt's lymphoma cell line.
Wolf J; Pawlita M; Jox A; Kohls S; Bartnitzke S; Diehl V; Bullerdiek J
Cancer Genet Cytogenet; 1993 Jun; 67(2):90-4. PubMed ID: 8392436
[TBL] [Abstract][Full Text] [Related]
18. Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype.
Chodosh J; Holder VP; Gan YJ; Belgaumi A; Sample J; Sixbey JW
J Infect Dis; 1998 May; 177(5):1194-201. PubMed ID: 9593003
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.
Hochberg D; Middeldorp JM; Catalina M; Sullivan JL; Luzuriaga K; Thorley-Lawson DA
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):239-44. PubMed ID: 14688409
[TBL] [Abstract][Full Text] [Related]
20. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
